header

R & D

RESEARCH & DEVELOPMENT

In Vitro Diagnostics (IVD)

SiaMed’Xpress has been the coordinator of the ANR-BiotecS TSH Testing (2011-2014). The project aimed at pioneering standardization of TSH immunoassays through a serum-like TSH standard. For this purpose, the company produced serum-like TSH and developed innovative immunoassays.


< Modeling of TSH structure. Alpha-subunit bears two N-glycans (in blue) and beta-subunit a single N-glycan (in green). Terminal sialic acid is represented in purple.

Therapeutics

SiaMed’Xpress develops glycoengineered cells with highly active sialyltransferases (in green) to produce glycoproteins with serum-like glycosylation (in red). With an experience in antibody engineering, the company develops long lasting molecules based on glyco-optimized profile.


< Left: mAb produced in CHO cells.
< Right: glyco-optimized mAb engineered with
SiaMed’Xpress technology.

bottom1
SiaMed’Xpress
Hôtel Technologique Morandat
1480 avenue d’Arménie - 13120 Gardanne - FRANCE
Tel: (+33) 442 644 903 / Email: contact@siamedxpress.com
Conception : Studio Créatis I Mentions légales